"10.1371_journal.ppat.1004046","plos pathogens","2014-03-27T00:00:00Z","Nazzarena Labo; Wendell Miley; Vickie Marshall; William Gillette; Dominic Esposito; Matthew Bess; Alexandra Turano; Thomas Uldrick; Mark N Polizzotto; Kathleen M Wyvill; Rachel Bagni; Robert Yarchoan; Denise Whitby","Viral Oncology Section, AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States of America; Protein Expression Laboratory, Advanced Technology Program, Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America; HIV and AIDS Malignancy Branch, National Cancer Institute, Bethesda, Maryland, United States of America","Conceived and designed the experiments: NL DW. Performed the experiments: WM VM AT MB. Analyzed the data: NL TU MNP RY RB MB. Contributed reagents/materials/analysis tools: WG DE. Wrote the paper: NL DW. Collected clinical data: TU. Designed and/or managed clinical protocols and provided patient care: TU MNP KMW RY.","I have read the journal's policy and have the following conflicts. The spouse of one of the authors (RY) is a coinventor on one or more patents related to an assay for the measurement of antibodies to KSHV viral IL-6. This work was done as a full-time employee of the US government under 45 Code of Federal Regulations Part 7. All rights, title, and interest to these patents have been or should by law be assigned to the U.S. Department of Health and Human Services. The government conveys a portion of the royalties it receives to its employee inventors under the Federal Technology Transfer Act of 1986 (P.L. 99-502). This does not alter our adherence to all PLOS policies on sharing data and materials.","2014","03","Nazzarena Labo","NL",13,TRUE,2,4,6,2,TRUE,TRUE,FALSE,0,NA,FALSE
